UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings

McColl, Barry W; Allan, Stuart M; McFall, Aisling; Hietamies, Tuuli M; Bernard, Ashton; Aimable, Margaux; Bath, Philip M; Brezzo, Gaia; Carare, Roxana O; Carswell, Hilary V; Clarkson, Andrew N; Currie, Gillian; Farr, Tracy D; Fowler, Jill; Good, Mark; Hainsworth, Atticus H; Hall, Catherine; Horsburgh, Karen; Kalaria, Rajesh; Kehoe, Patrick; Lawrence, Catherine; Macleod, Malcolm; McNeilly, Alison; Miller, Alyson A; Miners, Scott; Mok, Vincent; O'Sullivan, Michael; Platt, Bettina; Sena, Emily S; Sharp, Matthew; Strangeward, Patrick; Szymkowiak, Stefan; Touyz, Rhian M; Trueman, Rebecca C; White, Claire; McCabe, Chris; Work, Lorraine M; Quinn, Terence J

doi:10.1177/0271678x20910552

All Outputs (2)

CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model (2020)
Journal Article

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Myotonic dystrophy type 1 (DM1) is an RNA-based disease with no current treatment.... Read More about CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model.

UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings (2020)
Journal Article

© The Author(s) 2020. Assessment of outcome in preclinical studies of vascular cognitive impairment (VCI) is heterogenous. Through an ARUK Scottish Network supported questionnaire and workshop (mostly UK-based researchers), we aimed to determine unde... Read More about UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings.